Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

93 Results

Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Transcript : Canadian Utilities Limited - Shareholder/Analyst Call
UPM-Kymmene Corporation: Managers' Transactions (Maas-Brunner)
PU
UPM-Kymmene Corporation: Managers’ Transactions (Maas-Brunner)
GL
Henrik Ehrnrooth to continue as the Chair of the Board of Directors of UPM-Kymmene Corporation
GL
UPM Kymmene Oyj : Decisions of UPM-Kymmene Corporation's Annual General Meeting
PU
Decisions of UPM-Kymmene Corporation’s Annual General Meeting
GL
UPM-Kymmene Corporation Approves the Appointment of Melanie Maas-Brunner as Director to the Board
CI
Notice of the Annual General Meeting of UPM-Kymmene Corporation
GL
DD: BASF SE: Dr. Melanie Maas-Brunner, buy
EQ
BASF SE Announces Management Changes
CI
Dpa-AFX Overview: COMPANIES from 20.12.2023 - 15:15
DP
BASF CEO change in turbulent times: Kamieth moves to the top
DP
BASF Names Markus Kamieth to Succeed Martin Brudermueller as CEO -- 2nd Update
DJ
Management changes at BASF: Markus Kamieth to succeed Martin Brudermüller as Chairman of the Board of Executive Directors in 2024
PU
BASF says company veteran Kamieth to become CEO
RE
Siemens Energy: construction of electrolyzer with BASF
CF
BASF: green light for financing of PEM electrolyzer
CF
CO2-free hydrogen: BASF receives funding approval for 54-megawatt water electrolysis plant
PU
Industrial union IGBCE demonstrates for bridge electricity price
DP
Transcript : BASF SE, Q3 2023 Earnings Call, Oct 31, 2023
'HB': BASF boss wants to sell off parts of the group worth billions of euros
DP
BASF: Talks with chancellor only a first step toward a chemical pact
DP
BASF China boss Kamieth leads race for new CEO, FT says
RE
BASF : further expands its Innovation Campus Shanghai
PU
BASF celebrates 10 years of its Northeast Research Alliance
GL
BASF : strengthens R&D with more powerful supercomputer
PU
Tenants' association fears rent increases due to heating law
DP
EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results
GL
DD: BASF SE: Dr. Melanie Maas-Brunner, buy
EQ
DD: BASF SE: Dr. Melanie Maas-Brunner, buy
EQ
Transcript : BASF SE, 2022 Earnings Call, Feb 24, 2023
EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress
GL
EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress
GL
Scholz talks with chemical industry about location issues
DP
EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Sugemalimab in Metastatic Non-small Cell Lung Cancer
GL
EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Sugemalimab in Metastatic Non-small Cell Lung Cancer
AQ
EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer
GL
EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer
GL
R&D Webcast: Driving sustainability with microorganisms
PU
EQRx Provides Portfolio and U.S. Commercial Strategy Updates; Reports Third Quarter 2022 Financial Results
GL
EQRx Provides Portfolio and U.S. Commercial Strategy Updates; Reports Third Quarter 2022 Financial Results
AQ
Transcript : BASF SE, Q3 2022 Earnings Call, Oct 26, 2022
EQRx : Reports Second Quarter 2022 Financial Results and Recent Corporate Progress - Form 8-K
PU
EQRx Reports Second Quarter 2022 Financial Results and Recent Corporate Progress
GL
EQRx Reports Second Quarter 2022 Financial Results and Recent Corporate Progress
AQ
EQRx Announces Acceptance of Marketing Authorization Application by the UK's Medicines and Healthcare Products Regulatory Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer
GL
Transcript : Canadian Utilities Limited - Shareholder/Analyst Call
BASF SE : Notification and public disclosure of transactions by persons
EQ
IP : Crescendo Biologics Ltd - BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies
PU
BioNTech : and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies - Form 6-K
PU
No results for this search
  1. Stock Market
  2. Advanced search
  3. Melanie Maas-Brunner
  4. News